These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24086483)

  • 1. Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients.
    Liu L; Yuan G; Cheng Z; Zhang G; Liu X; Zhang H
    PLoS One; 2013; 8(9):e75259. PubMed ID: 24086483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia.
    Alvarez-Herrera S; Rosel Vales M; Pérez-Sánchez G; Becerril-Villanueva E; Flores-Medina Y; Maldonado-García JL; Saracco-Alvarez R; Escamilla R; Pavón L
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data.
    Jin M; Xie M; Dong L; Xue F; Li W; Jiang L; Li J; Zhang M; Song H; Lu Q; Yu Q
    Mol Neurobiol; 2024 Aug; 61(8):5992-6012. PubMed ID: 38267752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine, Immunity, and Disease.
    Channer B; Matt SM; Nickoloff-Bybel EA; Pappa V; Agarwal Y; Wickman J; Gaskill PJ
    Pharmacol Rev; 2023 Jan; 75(1):62-158. PubMed ID: 36757901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses.
    Gopinath A; Mackie PM; Phan LT; Mirabel R; Smith AR; Miller E; Franks S; Syed O; Riaz T; Law BK; Urs N; Khoshbouei H
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672204
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bahadory S; Sadraei J; Zibaei M; Pirestani M; Dalimi A
    Front Pharmacol; 2022; 13():878724. PubMed ID: 36204226
    [No Abstract]   [Full Text] [Related]  

  • 7. HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk.
    Yan Q; Wu X; Zhou P; Zhou Y; Li X; Liu Z; Tan H; Yao W; Xia Y; Zhu F
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine receptors in lymphocytes and their changes in schizophrenia.
    Penedo MA; Rivera-Baltanás T; Pérez-Rodríguez D; Allen J; Borrajo A; Alonso-Crespo D; Fernández-Pereira C; Nieto-Araujo M; Ramos-García S; Barreiro-Villar C; Caruncho HJ; Olivares JM; Agís-Balboa RC
    Brain Behav Immun Health; 2021 Mar; 12():100199. PubMed ID: 34589732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to study markers of dopamine signaling in peripheral immune cells.
    Gopinath A; Doty A; Mackie PM; Hashimi B; Francis M; Saadatpour L; Saha K; Shaw G; Ramirez-Zamora A; Okun MS; Streit WJ; Khoshbouei H
    J Immunol Methods; 2020 Jan; 476():112686. PubMed ID: 31634479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.
    Howell KR; Law AJ
    Schizophr Res; 2020 Mar; 217():95-104. PubMed ID: 31522868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.
    Taraskina AE; Nasyrova RF; Zabotina AM; Sosin DN; Sosina КА; Ershov EE; Grunina MN; Krupitsky EM
    BMC Psychiatry; 2017 Dec; 17(1):394. PubMed ID: 29221470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment.
    Liu L; Luo Y; Zhang G; Jin C; Zhou Z; Cheng Z; Yuan G
    Oncotarget; 2017 Oct; 8(49):86515-86526. PubMed ID: 29156812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic Biomarkers for Schizophrenia.
    Perkovic MN; Erjavec GN; Strac DS; Uzun S; Kozumplik O; Pivac N
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on the expression of
    Genis-Mendoza AD; Tovilla-Zárate CA; López-Narvaez L; Mendoza-Lorenzo P; Ostrosky-Wegman P; Nicolini H; González-Castro TB; Hernández-Diaz Y
    Hereditas; 2016; 153():13. PubMed ID: 28096775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory Effects Mediated by Dopamine.
    Arreola R; Alvarez-Herrera S; Pérez-Sánchez G; Becerril-Villanueva E; Cruz-Fuentes C; Flores-Gutierrez EO; Garcés-Alvarez ME; de la Cruz-Aguilera DL; Medina-Rivero E; Hurtado-Alvarado G; Quintero-Fabián S; Pavón L
    J Immunol Res; 2016; 2016():3160486. PubMed ID: 27795960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.
    Lai CY; Scarr E; Udawela M; Everall I; Chen WJ; Dean B
    World J Psychiatry; 2016 Mar; 6(1):102-17. PubMed ID: 27014601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts.
    Kennedy JL; Xiong N; Yu J; Zai CC; Pouget JG; Li J; Liu K; Qing H; Wang T; Martin E; Levy DL; Lin Z
    Schizophr Bull; 2016 May; 42(3):772-81. PubMed ID: 26707863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis.
    Cui Y; Prabhu V; Nguyen TB; Yadav BK; Chung YC
    Int J Mol Sci; 2015 Nov; 16(11):26677-86. PubMed ID: 26561806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.
    Debnath M
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):610-9. PubMed ID: 26162591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.